F-star Therapeutics, Inc. (FSTX) Earning

NASDAQ Currency in USD Disclaimer

$0.00

north_east NA Past Year
Day's range
$0
Day's range
$0

F-star Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/10/2022 Q3 2022 -$0.79 -$0.84 -0.05 N/A $1.13 M
08/11/2022 Q2 2022 -$0.58 -$0.89 -0.31 N/A $0
05/10/2022 Q1 2022 -$0.67 -$0.58 0.09 N/A $2.55 M
03/15/2022 Q4 2021 N/A $0.23 N/A N/A $17.50 M
11/10/2021 Q3 2021 -$0.58 -$0.52 0.06 N/A $751,000
08/13/2021 Q2 2021 N/A -$0.92 N/A N/A $0
05/17/2021 Q1 2021 -$1.16 -$1.08 0.08 N/A $2.92 M
03/30/2021 Q4 2020 N/A -$0.50 N/A N/A $163,000
11/03/2020 Q3 2020 -$1.00 -$0.38 0.62 N/A $9.20 M
08/10/2020 Q2 2020 -$1.44 -$0.71 0.73 N/A $543,000
05/07/2020 Q1 2020 -$0.80 -$0.79 0.01 N/A $1.36 M
11/07/2019 Q3 2019 -$2.43 -$0.00 2.43 N/A $0
07/31/2019 Q2 2019 -$2.22 -$0.00 2.22 N/A $0
04/29/2019 Q1 2019 -$2.09 -$0.00 2.09 N/A $0
10/25/2018 Q3 2018 -$0.61 -$0.00 0.61 N/A $0
08/02/2018 Q2 2018 N/A -$0.00 N/A N/A $0
04/27/2018 Q1 2018 -$0.57 -$0.00 0.57 N/A $0
10/31/2017 Q3 2017 -$0.49 -$0.00 0.49 N/A $0
07/31/2017 Q2 2017 -$0.45 -$0.00 0.45 N/A $0
04/28/2017 Q1 2017 -$0.47 -$0.00 0.47 N/A $0

F-star Therapeutics, Inc. Earnings: FAQ's

F-star Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 8th, 2023 based offlast year's report dates.

In the previous quarter, F-star Therapeutics, Inc. (:FSTX) reported $0.47 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.39 by $0.86.

The conference call for F-star Therapeutics, Inc.'s latest earnings report can be listened to online.

The conference call transcript for F-star Therapeutics, Inc.'s latest earnings report can be read online.

F-star Therapeutics, Inc. (:FSTX) has a recorded annual revenue of $21.17 M.

F-star Therapeutics, Inc. (:FSTX) has a recorded net income of $-31,283,000.F-star Therapeutics, Inc. has generated $-1.88 earnings per share over the last four quarters.

F-star Therapeutics, Inc. (:FSTX) has a price-to-earnings ratio of -3.79 and price/earnings-to-growth ratio is -0.04.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED